BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23461859)

  • 21. Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity.
    Kawamura K; Kadowaki N; Suzuki R; Udagawa S; Kasaoka S; Utoguchi N; Kitawaki T; Sugimoto N; Okada N; Maruyama K; Uchiyama T
    J Immunother; 2006; 29(2):165-74. PubMed ID: 16531817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes.
    Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP
    Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virosome-mediated delivery of protein antigens in vivo: efficient induction of class I MHC-restricted cytotoxic T lymphocyte activity.
    Bungener L; Huckriede A; de Mare A; de Vries-Idema J; Wilschut J; Daemen T
    Vaccine; 2005 Jan; 23(10):1232-41. PubMed ID: 15652665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T; Uehara S; Ariga H; Tokunaga T; Kariyone A; Tamura T; Takatsu K
    Immunology; 2006 Jan; 117(1):47-58. PubMed ID: 16423040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photochemical Internalization of Peptide Antigens Provides a Novel Strategy to Realize Therapeutic Cancer Vaccination.
    Haug M; Brede G; Håkerud M; Nedberg AG; Gederaas OA; Flo TH; Edwards VT; Selbo PK; Høgset A; Halaas Ø
    Front Immunol; 2018; 9():650. PubMed ID: 29670624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
    Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
    Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stroma-dependent development of two dendritic-like cell types with distinct antigen presenting capability.
    Periasamy P; O'Neill HC
    Exp Hematol; 2013 Mar; 41(3):281-92. PubMed ID: 23178375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitated antigen uptake and timed exposure to TLR ligands dictate the antigen-presenting potential of plasmacytoid DCs.
    Kool M; Geurtsvankessel C; Muskens F; Madeira FB; van Nimwegen M; Kuipers H; Thielemans K; Hoogsteden HC; Hammad H; Lambrecht BN
    J Leukoc Biol; 2011 Dec; 90(6):1177-90. PubMed ID: 21934071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cells.
    Lee JS; Kim SG; Kim HK; Lee TH; Jeong YI; Lee CM; Yoon MS; Na YJ; Suh DS; Park NC; Choi IH; Kim GY; Choi YH; Chung HY; Park YM
    J Cell Physiol; 2007 Feb; 210(2):385-97. PubMed ID: 17058260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
    Rosalia RA; Quakkelaar ED; Redeker A; Khan S; Camps M; Drijfhout JW; Silva AL; Jiskoot W; van Hall T; van Veelen PA; Janssen G; Franken K; Cruz LJ; Tromp A; Oostendorp J; van der Burg SH; Ossendorp F; Melief CJ
    Eur J Immunol; 2013 Oct; 43(10):2554-65. PubMed ID: 23836147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal injections of polyarginine-containing immunogenic antigens preferentially elicit Tc1 and Th1 activation and antitumour immunity.
    Mitsui H; Okamoto T; Kanzaki M; Inozume T; Shibagaki N; Shimada S
    Br J Dermatol; 2010 Jan; 162(1):29-41. PubMed ID: 19863514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
    Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
    Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells.
    Hotta C; Fujimaki H; Yoshinari M; Nakazawa M; Minami M
    Immunology; 2006 Jan; 117(1):97-107. PubMed ID: 16423045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination.
    Aarntzen EH; De Vries IJ; Lesterhuis WJ; Schuurhuis D; Jacobs JF; Bol K; Schreibelt G; Mus R; De Wilt JH; Haanen JB; Schadendorf D; Croockewit A; Blokx WA; Van Rossum MM; Kwok WW; Adema GJ; Punt CJ; Figdor CG
    Cancer Res; 2013 Jan; 73(1):19-29. PubMed ID: 23087058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody responses initiated by Clec9A-bearing dendritic cells in normal and Batf3(-/-) mice.
    Caminschi I; Vremec D; Ahmet F; Lahoud MH; Villadangos JA; Murphy KM; Heath WR; Shortman K
    Mol Immunol; 2012 Feb; 50(1-2):9-17. PubMed ID: 22209163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized carbon nanoparticles as an effective protein antigen delivery system targeting the cell-mediated immune response.
    Sawutdeechaikul P; Jiangchareon B; Wanichwecharungruang S; Palaga T
    Int J Nanomedicine; 2019; 14():4867-4880. PubMed ID: 31308663
    [No Abstract]   [Full Text] [Related]  

  • 38. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity.
    Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F
    ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes.
    Nakamura T; Moriguchi R; Kogure K; Shastri N; Harashima H
    Mol Ther; 2008 Aug; 16(8):1507-14. PubMed ID: 18560420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential cytosolic delivery and presentation of antigen by listeriolysin O-liposomes to macrophages and dendritic cells.
    Stier EM; Mandal M; Lee KD
    Mol Pharm; 2005; 2(1):74-82. PubMed ID: 15804180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.